Stem Cell Therapies in Orthopaedic Trauma

Summary: Stem cells offer great promise to help understand the normal mechanisms of tissue renewal, regeneration, and repair, and also for development of cell-based therapies to treat patients after tissue injury. Most adult tissues contain stem cells and progenitor cells that contribute to homeostasis, remodeling, and repair. Multiple stem and progenitor cell populations in bone are found in the marrow, the endosteum, and the periosteum. They contribute to the fracture healing process after injury and are an important component in tissue engineering approaches for bone repair. This review focuses on current concepts in stem cell biology related to fracture healing and bone tissue regeneration, as well as current strategies and limitations for clinical cell-based therapies.

[1]  D. Hu,et al.  The Multifaceted Role of the Vasculature in Endochondral Fracture Repair , 2015, Front. Endocrinol..

[2]  Jocelyn T. Compton,et al.  Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential , 2015, Cell.

[3]  P. Giannoudis,et al.  The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients , 2015, BMC Medicine.

[4]  J. M. Guimarães,et al.  The effect of autologous concentrated bone-marrow grafting on the healing of femoral shaft non-unions after locked intramedullary nailing. , 2014, Injury.

[5]  S. Morrison,et al.  Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. , 2014, Cell stem cell.

[6]  P. Giannoudis,et al.  Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results. , 2014, Injury.

[7]  D. Prockop,et al.  Concise Review: Two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation , 2013, Stem cells.

[8]  K. Tobita,et al.  Human Pericytes for Ischemic Heart Repair , 2013, Stem cells.

[9]  M. Tate,et al.  Current insights on the regenerative potential of the periosteum: Molecular, cellular, and endogenous engineering approaches , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  J. Marshall,et al.  Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials , 2012, PloS one.

[11]  Brian A. Aguado,et al.  Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. , 2012, Tissue engineering. Part A.

[12]  R. Midura,et al.  Stromal cell‐derived factor‐1 and monocyte chemotactic protein‐3 improve recruitment of osteogenic cells into sites of musculoskeletal repair , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[13]  I. Marzi,et al.  RIA reamings and hip aspirate: a comparative evaluation of osteoprogenitor and endothelial progenitor cells. , 2010, Injury.

[14]  Geert Carmeliet,et al.  Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. , 2010, Developmental cell.

[15]  D. Stewart,et al.  Endothelial progenitor cells promote fracture healing in a segmental bone defect model , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  E. Zocchi,et al.  The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. , 2010, Bone.

[17]  I. Marzi,et al.  Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. , 2010, Tissue engineering. Part A.

[18]  N. Rozen,et al.  Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. , 2009, Bone.

[19]  Anna Spagnoli,et al.  Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing , 2009, Stem cells.

[20]  F. Petrigliano,et al.  Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. , 2009, The Journal of bone and joint surgery. American volume.

[21]  Zhao-Jun Liu,et al.  Trafficking and differentiation of mesenchymal stem cells , 2009, Journal of cellular biochemistry.

[22]  M. Kurosaka,et al.  Local Delivery of Granulocyte Colony Stimulating Factor‐Mobilized CD34‐Positive Progenitor Cells Using Bioscaffold for Modality of Unhealing Bone Fracture , 2008, Stem cells.

[23]  S. McTaggart,et al.  Immunosuppression by mesenchymal stromal cells: from culture to clinic. , 2008, Experimental hematology.

[24]  Ken Kumagai,et al.  Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  Ken Kumagai,et al.  Cellular strategies for enhancement of fracture repair. , 2008, The Journal of bone and joint surgery. American volume.

[26]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[27]  Maurilio Marcacci,et al.  Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. , 2007, Tissue engineering.

[28]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[29]  D. Brodke,et al.  Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[30]  I. Ghiran,et al.  Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors , 2006, Stem cells.

[31]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[32]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[33]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[34]  K. Kraus,et al.  Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. , 2003, The Journal of bone and joint surgery. American volume.

[35]  R. Midura,et al.  Connective tissue progenitors: practical concepts for clinical applications. , 2002, Clinical orthopaedics and related research.

[36]  J. Connolly,et al.  Injectable bone marrow preparations to stimulate osteogenic repair. , 1995, Clinical orthopaedics and related research.

[37]  T. Hefferan,et al.  In vivo transplantation of autogenous marrow-derived cells following rapid intraoperative magnetic separation based on hyaluronan to augment bone regeneration. , 2013, Tissue engineering. Part A.

[38]  S. Giannotti,et al.  Treatment of pseudoarthrosis of the upper limb using expanded mesenchymal stem cells: a pilot study. , 2013, European review for medical and pharmacological sciences.

[39]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[40]  J. Mosca,et al.  T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. , 2005, Journal of biomedical science.

[41]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.